Health ❯Healthcare ❯Obesity

Weight Management

Diabetes Weight Loss Preventive Care Medical Treatments Treatment Strategies Hormones Pharmaceuticals Treatment Chronic Diseases Medical Research

Novo Nordisk’s Amycretin Achieves Up to 24% Weight Loss as It Advances to Phase 3

The phase 1 data reveal sustained weight reduction with tolerable gastrointestinal effects ahead of planned 2026 phase 3 trials.

Bariatric Surgery Surpasses GLP-1 Drugs in Real-World Weight Loss

Real-World GLP-1 Therapy Yields Lower Weight Loss, Spurs Tetra-Receptor Drug Research

Diabetes Drug Metformin Reduces Knee Pain in Osteoarthritis Patients, Study Finds